Bacterial cell wall peptidoglycan precursors (PG precursors)

Bacterial cell wall peptidoglycan precursors are essential metabolic intermediates required for the assembly of the peptidoglycan layer, which provides structural rigidity and osmotic protection to bacteria (Nature Reviews Microbiology, 2008). The most critical of these is Lipid II, a molecule composed of a disaccharide-pentapeptide unit anchored to the cytoplasmic membrane by an undecaprenyl lipid carrier (PubMed, 2013). These precursors are synthesized within the cell and flipped across the membrane to the periplasmic space, where they are polymerized into the existing cell wall by transglycosylases and transpeptidases (StatPearls, 2023). Because the peptidoglycan biosynthetic pathway is unique to prokaryotes, these precursors serve as highly selective targets for several classes of antibiotics (Journal of Biological Chemistry, 2010). Glycopeptide antibiotics, such as vancomycin, bind to the D-alanyl-D-alanine terminus of the pentapeptide, sterically hindering the enzymes responsible for cell wall cross-linking (NIH, 2022). Other agents, like bacitracin, target the lipid carrier recycling process by binding to undecaprenyl pyrophosphate (PubMed, 2012). This inhibition leads to cell wall instability, osmotic lysis, and bacterial death, making these precursors vital targets in treating Gram-positive infections (Clinical Microbiology Reviews, 2019). The emergence of resistance, such as through the modification of the D-Ala-D-Ala target to D-Ala-D-Lac, remains a significant clinical challenge (Nature, 2017).

Other names

Lipid IILipid IUDP-MurNAc-pentapeptidePark's nucleotideUndecaprenyl-pyrophosphate-linked precursors

Inhibition of peptidoglycan synthesis by binding to and sequestering precursors, specifically the D-Ala-D-Ala terminus or the pyrophosphate moiety, preventing their incorporation into the cell wall (Nature Reviews Microbiology, 2008; PubMed, 2013).